Karine Lacut

5.0k total citations · 1 hit paper
119 papers, 2.8k citations indexed

About

Karine Lacut is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Karine Lacut has authored 119 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Internal Medicine, 53 papers in Cardiology and Cardiovascular Medicine and 38 papers in Hematology. Recurrent topics in Karine Lacut's work include Venous Thromboembolism Diagnosis and Management (81 papers), Atrial Fibrillation Management and Outcomes (42 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Karine Lacut is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (81 papers), Atrial Fibrillation Management and Outcomes (42 papers) and Blood Coagulation and Thrombosis Mechanisms (33 papers). Karine Lacut collaborates with scholars based in France, Canada and Switzerland. Karine Lacut's co-authors include Dominique Mottier, Grégoire Le Gal, Emmanuel Oger, Jean‐François Abgrall, Françis Couturaud, Jean‐Christophe Cornily, Jacques Mansourati, Martine Gilard, Geneviève Le Calvez and J Boschat and has published in prestigious journals such as Blood, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Karine Lacut

114 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

2008 720 citations Martine Gilard, Arnaud Bertrand et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Karine Lacut

Since Specialization

Citations

This map shows the geographic impact of Karine Lacut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Lacut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Lacut more than expected).

Fields of papers citing papers by Karine Lacut

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Lacut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Lacut. The network helps show where Karine Lacut may publish in the future.

Co-authorship network of co-authors of Karine Lacut

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Lacut. A scholar is included among the top collaborators of Karine Lacut based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Lacut. Karine Lacut is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anticoagulation for VTE 2022 ·CHEST Journal ·(unknown), Raphaël Le Mao, Claire de Moreuil, Clément Hoffmann, Emmanuelle Le Moigne, Cécile Tromeur, (unknown), (unknown), Jean‐Christophe Gentric, Marie Guégan, (unknown), Luc Bressollette, Karine Lacut, (unknown), Françis Couturaud	3
2	Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study 2022 ·Thrombosis and Haemostasis ·(unknown), (unknown), Cécile Tromeur, Raphaël Le Mao, Clément Hoffmann, Emmanuelle Le Moigne, (unknown), Jean‐Christophe Gentric, Marie Guégan, (unknown), Luc Bressollette, Karine Lacut, Françis Couturaud, Romain Didier	4
3	Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-centre cohort study using the French national health data system 2022 ·European Journal of Clinical Pharmacology ·(unknown), Frédéric Balusson, Sandrine Kerbrat, Pierre‐Marie Roy, Damien Viglino, Karine Lacut, (unknown), Emmanuel Oger	2
4	Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis 2021 ·Thrombosis and Haemostasis ·(unknown), Clément Hoffmann, Cécile Tromeur, Romain Didier, Luc Bressollette, Karine Lacut, Françis Couturaud	7
5	Haematological parameters associated with postpartum haemorrhage after vaginal delivery: Results from a French cohort study 2021 ·Journal of Gynecology Obstetrics and Human Reproduction ·(unknown), Claire de Moreuil, (unknown), (unknown), (unknown), Florence Gatineau, Elisabeth Nowak, (unknown), (unknown), Emmanuelle Le Moigne, Philippe Merviel, (unknown), Karine Lacut, (unknown)	11
6	Attentes des patients asthmatiques vis-à-vis de leur prise en charge 2021 ·Revue des Maladies Respiratoires ·Raphaël Le Mao, Cécile Tromeur, Karine Lacut, Françis Couturaud, Jérôme Foucaud, Christophe Leroyer	1
7	Bleeding complications during pregnancy and delivery in haemophilia carriers and their neonates in Western France: An observational study 2020 ·Haemophilia ·(unknown), Benjamin Gillet, Benoît Guillet, Philippe Beurrier, (unknown), (unknown), (unknown), (unknown), Marc Trossaërt, (unknown), (unknown), J. Potin, (unknown), Laurent Macchi, Françis Couturaud, Karine Lacut, Brigitte Pan‐Petesch	5
8	Anticoagulants oraux directs : dans quelles indications ? Lequel prescrire ? Pour ou contre chez les personnes fragiles et dans les situations atypiques ? Quelle surveillance et gestion des accidents hémorragiques ? 2020 ·La Revue de Médecine Interne ·Clément Hoffmann, Cyril Leven, Raphaël Le Mao, Claire de Moreuil, Karine Lacut	2
9	Real-world incidence of cancer following a first unprovoked venous thrombosis: Results from the EPIGETBO study 2018 ·Thrombosis Research ·Aurélien Delluc, Jean‐Christophe Ianotto, Cécile Tromeur, Claire de Moreuil, Françis Couturaud, Karine Lacut, Emmanuelle Le Moigne, Patrick J. Louis, Jérémie Thereaux, Jean‐Philippe Metges, Dominique Mottier	14
10	Risk of recurrent venous thromboembolism in COPD patients: results from a prospective cohort study 2017 ·European Respiratory Journal ·Raphaël Le Mao, Cécile Tromeur, (unknown), Maëlenn Gouillou, Marie Guégan, Karine Lacut, Aurélien Delluc, Dominique Mottier, Christophe Leroyer, Françis Couturaud	14
11	Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study 2017 ·European Journal of Internal Medicine ·(unknown), (unknown), Cécile Tromeur, Karine Lacut, Grégoire Le Gal, Dominique Mottier, Françis Couturaud, Aurélien Delluc	5
12	Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study 2017 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), (unknown), Cécile Tromeur, Karine Lacut, Grégoire Le Gal, (unknown), Françis Couturaud, Aurélien Delluc	1
13	Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism 2017 ·PLoS ONE ·Philippe Robin, Pierre‐Yves Le Roux, Karine Lacut, Benjamin Planquette, (unknown), Christian Lavigne, Jean Pastré, A. Merah, Grégoire Le Gal, Pierre‐Yves Salaün	4
14	Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France 2016 ·Thrombosis and Haemostasis ·Aurélien Delluc, Cécile Tromeur, Florent Le Ven, Maëlenn Gouillou, N. Paleiron, Luc Bressollette, Michel Nonent, Pierre‐Yves Salaün, Karine Lacut, Christophe Leroyer, Grégoire Le Gal, Françis Couturaud, Dominique Mottier, (unknown)	71
15	Reduction of coagulability state one year after bariatric surgery 2016 ·Surgery for Obesity and Related Diseases ·Jérémie Thereaux, (unknown), (unknown), Hubert Galinat, Françis Couturaud, Karine Lacut	14
16	A model predicting fluindione dose requirement in elderly inpatients including genotypes, body weight, and amiodarone 2013 ·Thrombosis and Haemostasis ·Caroline Moreau, Éric Pautas, (unknown), (unknown), (unknown), Isabelle Mahé, Joseph Emmerich, Karine Lacut, Grégoire Le Gal, (unknown), Isabelle Gouin‐Thibault, Jean-Louis Golmard, Marie‐Anne Loriot, Virginie Siguret	3
17	Antihypertensive drugs and risk of venous thromboembolism: results from the EDITH case–control study 2009 ·Fundamental and Clinical Pharmacology ·(unknown), Aurélien Delluc, Grégoire Le Gal, Christophe Leroyer, Dominique Mottier, Emmanuel Oger, Karine Lacut	0
18	Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin breakdown → 2008 ·Journal of the American College of Cardiology ·Martine Gilard, Arnaud Bertrand, Jean‐Christophe Cornily, Grégoire Le Gal, Karine Lacut, Geneviève Le Calvez, Jacques Mansourati, Dominique Mottier, Jean‐François Abgrall, J Boschat	720
19	Family history as a risk factor for venous thromboembolism 2008 ·Thrombosis Research ·(unknown), Grégoire Le Gal, Karine Lacut, Bernard Mercier, Christophe Leroyer, Emmanuel Nowak, Dominique Mottier, Emmanuel Oger	55
20	Antivitamine K dans la prévention au long cours : quel degré d’anticoagulation, pour quelle efficacité et quel risque ? 2005 ·Sang thrombose vaisseaux ·Françis Couturaud, Karine Lacut, Christophe Gut‐Gobert, Christophe Leroyer, Dominique Mottier	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact